Woojin An, PhD

Title(s)Professor of Biochemistry & Molecular Medicine
SchoolKeck School of Medicine of Usc
AddressNRT 6507, NRT 6513A, 1450 Biggy Street
Health Sciences Campus
Los Angeles CA 90089
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. An is a Professor of Biochemistry and Molecular Medicine at the Keck School of Medicine of USC. His research program is focused on using multi-disciplinary biochemical and cellular approaches to understand fundamental concepts and mechanisms of action of epigenetic histone remodeling in various cellular events. Specifically, his laboratory employs multiple assay systems and methods to dissect molecular details of how histone modification, histone variant exchange, and histone tail proteolysis regulate chromatin structure and control gene expression processes. Current projects involve genome-wide location analysis and functional characterization of histone marks and downstream effectors that are crucial for epigenetic regulation of cell growth, differentiation, and transformation. Dr. An received his Ph.D. in Biochemistry and Biophysics in 1998 from the Oregon State University and did his postdoctoral training at the Rockefeller University. He began his career on the faculty at USC in 2004.

    Collapse Research 
    Collapse Research Activities and Funding
    Epigenetic Regulation of Osteoclastogenic Gene Expression: Factors, Targets, and Mechanisms
    NIH R01AR073233Aug 1, 2019 - May 31, 2024
    Role: Principal Investigator
    Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation
    NIH R01CA201561Jul 15, 2016 - Jun 30, 2021
    Role: Principal Investigator
    ROLE OF HISTONE H4 N-TERMINAL TAIL IN TRANSCRIPTION REGULATION
    NIH R01GM084209Aug 1, 2008 - Jul 31, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis. Sci Rep. 2024 05 21; 14(1):11595. Shin Y, Kim S, An W. PMID: 38773164; PMCID: PMC11109272.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis. Mol Oncol. 2024 Aug; 18(8):2001-2019. Shin Y, Kim S, Liang G, An W. PMID: 38600695; PMCID: PMC11306514.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    3. Non-canonical MLL1 activity regulates centromeric phase separation and genome stability. Nat Cell Biol. 2023 Nov; 25(11):1637-1649. Sha L, Yang Z, An S, Yang W, Kim S, Oh H, Xu J, Yin J, Wang H, Lenz HJ, An W, Cho US, Dou Y. PMID: 37945831; PMCID: PMC11345869.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    4. VprBP/DCAF1 Triggers Melanomagenic Gene Silencing through Histone H2A Phosphorylation. Biomedicines. 2023 Sep 17; 11(9). Shin Y, Kim S, Liang G, Ulmer TS, An W. PMID: 37760992; PMCID: PMC10526264.
      View in: PubMed   Mentions: 2  
    5. Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer. Nat Commun. 2023 04 17; 14(1):2140. Ghate NB, Kim S, Shin Y, Kim J, Doche M, Valena S, Situ A, Kim S, Rhie SK, Lenz HJ, Ulmer TS, Mumenthaler SM, An W. PMID: 37069142; PMCID: PMC10110550.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    6. VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation. Oncogene. 2023 04; 42(17):1405-1416. Ghate NB, Kim S, Mehmood R, Shin Y, Kim K, An W. PMID: 37041410; PMCID: PMC10121470.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    7. DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma. Cancer Lett. 2022 11 01; 548:215899. Zhang L, Li HT, Shereda R, Lu Q, Weisenberger DJ, O'Connell C, Machida K, An W, Lenz HJ, El-Khoueiry A, Jones PA, Liu M, Liang G. PMID: 36087682; PMCID: PMC9563073.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    8. MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis. Oncogene. 2022 01; 41(4):560-570. Shin Y, Kim S, Ghate NB, Rhie SK, An W. PMID: 34785776.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    9. VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer. Mol Oncol. 2021 10; 15(10):2801-2817. Ghate NB, Kim S, Spiller E, Kim S, Shin Y, Rhie SK, Smbatyan G, Lenz HJ, Mumenthaler SM, An W. PMID: 34312968; PMCID: PMC8486565.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    10. MMP-2 is a novel histone H3 N-terminal protease necessary for myogenic gene activation. Epigenetics Chromatin. 2021 05 17; 14(1):23. Rice JC, Weekley BH, Kanholm T, Chen Z, Lee S, Fernandez DJ, Abrahamson R, Castaldi A, Borok Z, Dynlacht BD, An W. PMID: 34001241; PMCID: PMC8130154.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    11. Insight Into Pathological Integrin αIIbβ3 Activation From Safeguarding The Inactive State. J Mol Biol. 2021 04 02; 433(7):166832. Situ AJ, Kim J, An W, Kim C, Ulmer TS. PMID: 33539882; PMCID: PMC11025565.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. A HOTAIR regulatory element modulates glioma cell sensitivity to temozolomide through long-range regulation of multiple target genes. Genome Res. 2020 02; 30(2):155-163. Zhang L, He A, Chen B, Bi J, Chen J, Guo D, Qian Y, Wang W, Shi T, Zhao Z, Shi J, An W, Attenello F, Lu W. PMID: 31953347; PMCID: PMC7050528.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    13. Epigenetic Modification as a Regulatory Mechanism for Spatiotemporal Dynamics of ANO1 Expression in Salivary Glands. Int J Mol Sci. 2019 Dec 13; 20(24). Shin Y, Lee SW, Namkoong E, An W, Lee JH, Brown PD, Park K. PMID: 31847128; PMCID: PMC6940850.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    14. p32 is a negative regulator of p53 tetramerization and transactivation. Mol Oncol. 2019 09; 13(9):1976-1992. Ghate NB, Kim J, Shin Y, Situ A, Ulmer TS, An W. PMID: 31293051; PMCID: PMC6717765.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    15. DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis. Epigenetics Chromatin. 2019 04 16; 12(1):25. Shin Y, Ghate NB, Moon B, Park K, Lu W, An W. PMID: 30992059; PMCID: PMC6466663.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    16. Regulation of Breast Cancer-Induced Osteoclastogenesis by MacroH2A1.2 Involving EZH2-Mediated H3K27me3. Cell Rep. 2018 07 03; 24(1):224-237. Kim J, Shin Y, Lee S, Kim M, Punj V, Lu JF, Shin H, Kim K, Ulmer TS, Koh J, Jeong D, An W. PMID: 29972783; PMCID: PMC6061927.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    17. MacroH2A1.2 inhibits prostate cancer-induced osteoclastogenesis through cooperation with HP1α and H1.2. Oncogene. 2018 10; 37(43):5749-5765. Kim JM, Shin Y, Lee S, Kim MY, Punj V, Shin HI, Kim K, Koh JM, Jeong D, An W. PMID: 29925860; PMCID: PMC6309402.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    18. H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis. Epigenetics Chromatin. 2018 05 28; 11(1):23. Kim K, Shin Y, Kim J, Ulmer TS, An W. PMID: 29807539; PMCID: PMC5971420.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    19. Membrane Anchoring of α-Helical Proteins: Role of Tryptophan. J Phys Chem B. 2018 01 25; 122(3):1185-1194. Situ AJ, Kang SM, Frey BB, An W, Kim C, Ulmer TS. PMID: 29323921; PMCID: PMC11025564.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    20. Role of remodeling and spacing factor 1 in histone H2A ubiquitination-mediated gene silencing. Proc Natl Acad Sci U S A. 2017 09 19; 114(38):E7949-E7958. Zhang Z, Jones AE, Wu W, Kim J, Kang Y, Bi X, Gu Y, Popov IK, Renfrow MB, Vassylyeva MN, Vassylyev DG, Giles KE, Chen D, Kumar A, Fan Y, Tong Y, Liu CF, An W, Chang C, Luo J, Chow LT, Wang H. PMID: 28855339; PMCID: PMC5617306.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    21. Correction for Kim et al., "Vpr-Binding Protein Antagonizes p53-Mediated Transcription via Direct Interaction with H3 Tail". Mol Cell Biol. 2017 08 01; 37(15). Kim K, Heo K, Choi J, Jackson S, Kim H, Xiong Y, An W. PMID: 28710123; PMCID: PMC5514449.
      View in: PubMed   Mentions:    Fields:    
    22. A Conserved Ectodomain-Transmembrane Domain Linker Motif Tunes the Allosteric Regulation of Cell Surface Receptors. J Biol Chem. 2016 08 19; 291(34):17536-46. Schmidt T, Ye F, Situ AJ, An W, Ginsberg MH, Ulmer TS. PMID: 27365391; PMCID: PMC5016151.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    23. MMP-9 facilitates selective proteolysis of the histone H3 tail at genes necessary for proficient osteoclastogenesis. Genes Dev. 2016 Jan 15; 30(2):208-19. Kim K, Punj V, Kim JM, Lee S, Ulmer TS, Lu W, Rice JC, An W. PMID: 26744418; PMCID: PMC4719310.
      View in: PubMed   Mentions: 57     Fields:    Translation:AnimalsCells
    24. Linker histone H1.2 establishes chromatin compaction and gene silencing through recognition of H3K27me3. Sci Rep. 2015 Nov 19; 5:16714. Kim JM, Kim K, Punj V, Liang G, Ulmer TS, Lu W, An W. PMID: 26581166; PMCID: PMC4652225.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    25. Analysis of a transgenic Oct4 enhancer reveals high fidelity long-range chromosomal interactions. Sci Rep. 2015 Oct 05; 5:14558. Cai M, Gao F, Zhang P, An W, Shi J, Wang K, Lu W. PMID: 26435056; PMCID: PMC4592970.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    26. Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells. Nucleic Acids Res. 2015 Oct 15; 43(18):8868-83. Kim JM, Kim K, Schmidt T, Punj V, Tucker H, Rice JC, Ulmer TS, An W. PMID: 26350217; PMCID: PMC4605318.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    27. Linker Histone H1.2 cooperates with Cul4A and PAF1 to drive H4K31 ubiquitylation-mediated transactivation. Cell Rep. 2013 Dec 26; 5(6):1690-703. Kim K, Lee B, Kim J, Choi J, Kim JM, Xiong Y, Roeder RG, An W. PMID: 24360965; PMCID: PMC3901356.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    28. The histone variant MacroH2A regulates Ca(2+) influx through TRPC3 and TRPC6 channels. Oncogenesis. 2013 Oct 28; 2:e77. Kim JM, Heo K, Choi J, Kim K, An W. PMID: 24165580; PMCID: PMC3816217.
      View in: PubMed   Mentions: 23  
    29. VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription. Mol Cell. 2013 Nov 07; 52(3):459-67. Kim K, Kim JM, Kim JS, Choi J, Lee YS, Neamati N, Song JS, Heo K, An W. PMID: 24140421; PMCID: PMC3851289.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    30. Gene dysregulation by histone variant H2A.Z in bladder cancer. Epigenetics Chromatin. 2013 Oct 16; 6(1):34. Kim K, Punj V, Choi J, Heo K, Kim JM, Laird PW, An W. PMID: 24279307; PMCID: PMC3853418.
      View in: PubMed   Mentions: 50     Fields:    
    31. Nuclear CaMKII enhances histone H3 phosphorylation and remodels chromatin during cardiac hypertrophy. Nucleic Acids Res. 2013 09; 41(16):7656-72. Awad S, Kunhi M, Little GH, Bai Y, An W, Bers D, Kedes L, Poizat C. PMID: 23804765; PMCID: PMC3763528.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    32. Biological implications and regulatory mechanisms of long-range chromosomal interactions. J Biol Chem. 2013 Aug 02; 288(31):22369-77. Wei Z, Huang D, Gao F, Chang WH, An W, Coetzee GA, Wang K, Lu W. PMID: 23779110; PMCID: PMC3829327.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    33. Klf4 organizes long-range chromosomal interactions with the oct4 locus in reprogramming and pluripotency. Cell Stem Cell. 2013 Jul 03; 13(1):36-47. Wei Z, Gao F, Kim S, Yang H, Lyu J, An W, Wang K, Lu W. PMID: 23747203.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansAnimalsCells
    34. The interactomes of POU5F1 and SOX2 enhancers in human embryonic stem cells. Sci Rep. 2013; 3:1588. Gao F, Wei Z, An W, Wang K, Lu W. PMID: 23549118; PMCID: PMC4070749.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    35. An essential role of variant histone H3.3 for ectomesenchyme potential of the cranial neural crest. PLoS Genet. 2012 Sep; 8(9):e1002938. Cox SG, Kim H, Garnett AT, Medeiros DM, An W, Crump JG. PMID: 23028350; PMCID: PMC3447937.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    36. Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1. Oncogene. 2013 May 16; 32(20):2510-20. Heo K, Kim JS, Kim K, Kim H, Choi J, Yang K, An W. PMID: 22751130.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    37. Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription. Oncogene. 2012 Sep 27; 31(39):4290-301. Kim K, Jeong KW, Kim H, Choi J, Lu W, Stallcup MR, An W. PMID: 22249259; PMCID: PMC3330162.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    38. Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail. Mol Cell Biol. 2012 Feb; 32(4):783-96. Kim K, Heo K, Choi J, Jackson S, Kim H, Xiong Y, An W. PMID: 22184063; PMCID: PMC3272969.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    39. p53 requires an intact C-terminal domain for DNA binding and transactivation. J Mol Biol. 2012 Feb 03; 415(5):843-54. Kim H, Kim K, Choi J, Heo K, Baek HJ, Roeder RG, An W. PMID: 22178617; PMCID: PMC3267882.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    40. Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation. Nat Struct Mol Biol. 2011 Nov 13; 18(12):1358-65. Jeong KW, Kim K, Situ AJ, Ulmer TS, An W, Stallcup MR. PMID: 22081016; PMCID: PMC3230772.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    41. Selective requirement of H2B N-Terminal tail for p14ARF-induced chromatin silencing. Nucleic Acids Res. 2011 Nov; 39(21):9167-80. Choi J, Kim H, Kim K, Lee B, Lu W, An W. PMID: 21846774; PMCID: PMC3241654.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    42. Histone variant H3.3 stimulates HSP70 transcription through cooperation with HP1γ. Nucleic Acids Res. 2011 Oct; 39(19):8329-41. Kim H, Heo K, Choi J, Kim K, An W. PMID: 21742762; PMCID: PMC3201866.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    43. Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Res. 2011 Jan; 39(1):104-18. Choi SH, Heo K, Byun HM, An W, Lu W, Yang AS. PMID: 20841325; PMCID: PMC3017615.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    44. Cooperative action of TIP48 and TIP49 in H2A.Z exchange catalyzed by acetylation of nucleosomal H2A. Nucleic Acids Res. 2009 Oct; 37(18):5993-6007. Choi J, Heo K, An W. PMID: 19696079; PMCID: PMC2764430.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    45. Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription. J Biol Chem. 2009 Jul 24; 284(30):19867-77. Kim H, Heo K, Kim JH, Kim K, Choi J, An W. PMID: 19509295; PMCID: PMC2740412.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    46. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol Cell. 2008 Aug 22; 31(4):510-519. Kim JH, Yang CK, Heo K, Roeder RG, An W, Stallcup MR. PMID: 18722177; PMCID: PMC2562329.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansAnimalsCells
    47. 30 nm chromatin fibre decompaction requires both H4-K16 acetylation and linker histone eviction. J Mol Biol. 2008 Sep 12; 381(4):816-25. Robinson PJ, An W, Routh A, Martino F, Chapman L, Roeder RG, Rhodes D. PMID: 18653199; PMCID: PMC3870898.
      View in: PubMed   Mentions: 154     Fields:    Translation:AnimalsCells
    48. FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16. Mol Cell. 2008 Apr 11; 30(1):86-97. Heo K, Kim H, Choi SH, Choi J, Kim K, Gu J, Lieber MR, Yang AS, An W. PMID: 18406329.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansAnimalsCells
    49. Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription. J Biol Chem. 2008 Apr 04; 283(14):9113-26. Kim K, Choi J, Heo K, Kim H, Levens D, Kohno K, Johnson EM, Brock HW, An W. PMID: 18258596; PMCID: PMC2431041.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    50. Purification and characterization of cellular proteins associated with histone H4 tails. J Biol Chem. 2007 Jul 20; 282(29):21024-31. Choi J, Kim B, Heo K, Kim K, Kim H, Zhan Y, Ranish JA, An W. PMID: 17548343.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    51. Isolation and characterization of proteins associated with histone H3 tails in vivo. J Biol Chem. 2007 May 25; 282(21):15476-83. Heo K, Kim B, Kim K, Choi J, Kim H, Zhan Y, Ranish JA, An W. PMID: 17403666.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    52. Histone acetylation and methylation: combinatorial players for transcriptional regulation. Subcell Biochem. 2007; 41:351-69. An W. PMID: 17484136.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    53. Mechanism of polymerase II transcription repression by the histone variant macroH2A. Mol Cell Biol. 2006 Feb; 26(3):1156-64. Doyen CM, An W, Angelov D, Bondarenko V, Mietton F, Studitsky VM, Hamiche A, Roeder RG, Bouvet P, Dimitrov S. PMID: 16428466; PMCID: PMC1347033.
      View in: PubMed   Mentions: 72     Fields:    Translation:AnimalsCells
    54. SWI/SNF remodeling and p300-dependent transcription of histone variant H2ABbd nucleosomal arrays. EMBO J. 2004 Oct 01; 23(19):3815-24. Angelov D, Verdel A, An W, Bondarenko V, Hans F, Doyen CM, Studitsky VM, Hamiche A, Roeder RG, Bouvet P, Dimitrov S. PMID: 15372075; PMCID: PMC522799.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    55. Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell. 2004 Jun 11; 117(6):735-48. An W, Kim J, Roeder RG. PMID: 15186775.
      View in: PubMed   Mentions: 234     Fields:    Translation:HumansAnimalsCells
    56. Regulation of the p300 HAT domain via a novel activation loop. Nat Struct Mol Biol. 2004 Apr; 11(4):308-15. Thompson PR, Wang D, Wang L, Fulco M, Pediconi N, Zhang D, An W, Ge Q, Roeder RG, Wong J, Levrero M, Sartorelli V, Cotter RJ, Cole PA. PMID: 15004546.
      View in: PubMed   Mentions: 203     Fields:    Translation:AnimalsCells
    57. Reconstitution and transcriptional analysis of chromatin in vitro. Methods Enzymol. 2004; 377:460-74. An W, Roeder RG. PMID: 14979045.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    58. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell. 2003 Aug; 12(2):475-87. Wang H, An W, Cao R, Xia L, Erdjument-Bromage H, Chatton B, Tempst P, Roeder RG, Zhang Y. PMID: 14536086.
      View in: PubMed   Mentions: 148     Fields:    Translation:HumansAnimalsCells
    59. Direct association of p300 with unmodified H3 and H4 N termini modulates p300-dependent acetylation and transcription of nucleosomal templates. J Biol Chem. 2003 Jan 17; 278(3):1504-10. An W, Roeder RG. PMID: 12421817.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    60. Selective requirements for histone H3 and H4 N termini in p300-dependent transcriptional activation from chromatin. Mol Cell. 2002 Apr; 9(4):811-21. An W, Palhan VB, Karymov MA, Leuba SH, Roeder RG. PMID: 11983172.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    61. SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem. 2002 Feb 15; 277(7):5498-505. Kato H, Tjernberg A, Zhang W, Krutchinsky AN, An W, Takeuchi T, Ohtsuki Y, Sugano S, de Bruijn DR, Chait BT, Roeder RG. PMID: 11734557.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    62. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol Cell. 2000 Sep; 6(3):551-61. Kundu TK, Palhan VB, Wang Z, An W, Cole PA, Roeder RG. PMID: 11030335.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    63. The site of binding of linker histone to the nucleosome does not depend upon the amino termini of core histones. Biochimie. 1999 Jul; 81(7):727-32. An W, Zlatanova J, Leuba SH, van Holde K. PMID: 10492019.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    64. The non-histone chromatin protein HMG1 protects linker DNA on the side opposite to that protected by linker histones. J Biol Chem. 1998 Oct 09; 273(41):26289-91. An W, van Holde K, Zlatanova J. PMID: 9756855.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    65. Linker histone protection of chromatosomes reconstituted on 5S rDNA from Xenopus borealis:a reinvestigation. Nucleic Acids Res. 1998 Sep 01; 26(17):4042-6. An W, van Holde K, Zlatanova J. PMID: 9705517; PMCID: PMC147788.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    66. Linker histone protects linker DNA on only one side of the core particle and in a sequence-dependent manner. Proc Natl Acad Sci U S A. 1998 Mar 31; 95(7):3396-401. An W, Leuba SH, van Holde K, Zlatanova J. PMID: 9520377; PMCID: PMC19847.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    Woojin's Networks
    Concepts (286)
    Derived automatically from this person's publications.
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _